RPL35 and infection: Experiments with this quiescence infection model indicated that anti-HSV-1 gRNAs targeting four viral essential genes (UL29, UL30, UL54/ICP27, and ICP4) could reduce reactivation of quiescent HSV-1 d109 genomes.20